Differential effects of volatile anesthetics on M3 muscarinic receptor coupling to the Gαq heterotrimeric G protein

Anesthesiology

Volumn 105, Issue 2, 2006, Pages 313-324

  Nakayama, Tetsuzo ^a   Penheiter, Alan R ^a   Penheiter, Sumedha G ^a   Chini, Eduardo N ^a   Thompson, Michael ^a   Warner, David O ^a   Jones, Keith A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE TRIPHOSPHATE; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; MUSCARINIC M3 RECEPTOR; SEVOFLURANE;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL STRAIN COS7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETYLCHOLINE; ALGORITHMS; ANESTHETICS, INHALATION; ANIMALS; CALCIUM; CELL MEMBRANE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOPLASM; DATA INTERPRETATION, STATISTICAL; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; GUANINE NUCLEOTIDES; HALOTHANE; HEXANOLS; HUMANS; IMMUNOBLOTTING; ISOFLURANE; ISOMETRIC CONTRACTION; METHYL ETHERS; RECEPTOR, MUSCARINIC M3;

EID: 33746603959     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200608000-00014     Document Type: Article

References (54)

1. Padkin AJ, Baigel G, Morgan GA: Halothane treatment of severe asthma to avoid mechanical ventilation. Anaesthesia 1997; 52:994-7
2. Oliver WC Jr, Murray MJ, Raimundo HS, Puga FJ: The use of halothane to treat severe bronchospasm after a unifocalization procedure. J Cardiothorac Vasc Anesth 1995; 9:177-80
3. DeNicola LK, Gayle MO, Blake KV: Drug therapy approaches in the treatment of acute severe asthma in hospitalised children. Paediatr Drugs 2001; 3:509-37
4. Baigel G: Volatile agents to avoid ventilating asthmatics. Anaesth Intensive Care 2003; 31:208-10
5. Saulnier FF, Durocher AV, Deturck RA, Lefebvre MC, Wattel FE: Respiratory and hemodynamic effects of halothane in status asthmaticus. Intensive Care Med 1990; 16:104-7
6. Jones KA, Housmans PR, Warner DO, Lorenz RR, Rehder K: Halothane alters cytosolic calcium transient in tracheal smooth muscle. Am J Physiol 1993; 265:L80-6
7. 2+ concentration. Anesth Analg 1993; 77:67-72
8. 2+ in airway smooth muscle independently of cyclic nucleotides. Am J Physiol 1995; 268:L166-72
9. Yamakage M: Direct inhibitory mechanisms of halothane on canine tracheal smooth muscle contraction. ANESTHESIOLOGY 1992; 77:546-53
10. 2+ sensitivity during muscarinic receptor stimulation of airway smooth muscle. Am J Physiol 1996; 271:L719-25
11. Bremerich DH, Hirasaki A, Jones KA, Warner DO: Halothane attenuation of calcium sensitivity in airway smooth muscle: Mechanisms of action during muscarinic receptor stimulation. ANESTHESIOLOGY 1997; 87:94-101
12. Jones KA, Wong GY, Lorenz RR, Warner DO, Sieck GC: Effects of halothane on the relationship between cytosolic calcium and force in airway smooth muscle. Am J Physiol 1994; 266:L199-204
13. Nakayama T, Hayashi M, Warner DO, Jones KA: Anesthetics inhibit membrane receptor coupling to the Gq/11 heterotrimeric G-protein in airway smooth muscle. ANESTHESIOLOGY 2005; 103:296-305
14. Gerthoffer WT: Agonist synergism in airway smooth muscle contraction. J Pharmacol Exp Ther 1996; 278:800-7
15. 2+ sensitization of tracheal smooth muscle. Am J Physiol 1998; 275:L748-55
16. Jones KA, Hirasaki A, Bremerich DH, Jankowski C, Warner DO: Halothane inhibits agonist-induced potentiation of rMLC phosphorylation in permeabilized airway smooth muscle. Am J Physiol 1997; 273:L80-5
17. Yoshimura H, Jones KA, Perkins WJ, Kai T, Warner DO: Calcium sensitization produced by G protein activation in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2001; 281:L631-8
18. Somlyo AP, Somlyo AV: Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol (Lond) 2000; 522(pt 2):177-85
19. 2+ sensitivity of smooth muscle and nonmuscle myosin II: Modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003; 83:1325-58
20. 2+ sensitization in airway smooth muscle. Anesth Analg 1998; 87:425-9
21. Yoshimura H, Jones KA, Perkins WJ, Warner DO: Dual effects of hexanol and halothane on the regulation of calcium sensitivity in airway smooth muscle. ANESTHESIOLOGY 2003; 98:871-80
22. Kai T, Jones KA, Warner DO: Halothane attenuates calcium sensitization in airway smooth muscle by inhibiting G-proteins. ANESTHESIOLOGY 1998; 89:1543-52
23. Sakihara C, Perkins WJ, Warner DO, Jones KA: Anesthetics inhibit acetylcholine-promoted guanine nucleotide exchange of heterotrimeric G proteins of airway smooth muscle. ANESTHESIOLOGY 2004; 101:120-6
24. Kai T, Yoshimura H, Jones KA, Warner DO: Relationship between force and regulatory myosin light chain phosphorylation in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2000; 279:L52-8
25. Fabiato A, Fabiato F: Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells. J Physiol (Paris) 1979; 75:463-505
26. Jin F, Wang S, Spencer JD, Penheiter SG, Streiff JH, Penheiter AR, Warner DO, Jones KA: Effect of halothane on Gαi-3 and its coupling to the M2 muscarinic receptor. ANESTHESIOLOGY 2005; 103:1015-25
27. 2+ transients: Modulation by progesterone. Am J Physiol Endocrinol Metab 2004; 287:E1142-8
28. Pabelick CM, Prakash YS, Kannan MS, Warner DO, Sieck GC: Effects of halothane on sarcoplasmic reticulum calcium release channels in porcine airway smooth muscle cells. ANESTHESIOLOGY 2001; 95:207-15
29. Lowry AH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin reagent. J Biol Chem 1951; 193:265-75
30. Barr AJ, Brass LF, Manning DR: Reconstitution of receptors and GTP-binding regulatory proteins (G proteins) in Sf9 cells: A direct evaluation of selectivity in receptor G protein coupling. J Biol Chem 1997; 272:2223-9
31. Hollmann MW, Ritter CH, Henle P, de Klaver M, Kamatchi GL, Durieux ME: Inhibition of m3 muscarinic acetylcholine receptors by local anaesthetics. Br J Pharmacol 2001; 133:207-16
32. Bylund DB, Deupree JD, Toews ML: Radioligand-binding methods for membrane preparations and intact cells. Methods Mol Biol 2004; 259:1-28
33. Streiff J, Jones K, Perkins WJ, Warner DO, Jones KA: Effect of halothane on the guanosine 5′ triphosphate binding activity of G-protein αi subunits. ANESTHESIOLOGY 2003; 99:105-11
34. Pentyala SN, Sung K, Chowdhury A, Rebecchi MJ: Volatile anesthetics modulate the binding of guanine nucleotides to the alpha subunits of heterotrimeric GTP binding proteins. Eur J Pharmacol 1999; 384:213-22
35. Van Dyke RA, Wood CL: Binding of radioactivity from 14 C-labeled halothane in isolated perfused rat livers. ANESTHESIOLOGY 1973; 38:328-32
36. Streiff J, Warner DO, Klimtchuk E, Perkins WJ, Jones K, Jones KA: The effects of hexanol on Galpha(i) subunits of heterotrimeric G proteins. Anesth Analg 2004; 98:660-7
37. Sakihara C, Jones KA, Lorenz RR, Perkins WJ, Warner DO: Effects of primary alcohols on airway smooth muscle. ANESTHESIOLOGY 2002; 96:428-37
38. Zeng FY, Wess J: Identification and molecular characterization of m3 muscarinic receptor dimers. J Biol Chem 1999; 274:19487-97
39. Kuhn B, Schmid A, Harteneck C, Gudermann T, Schultz G: G proteins of the Gq family couple the H2 histamine receptor to phospholipase C. Mol Endocrinol 1996; 10:1697-707
40. Seto T, Mashimo T, Yoshiya I, Kanashiro M, Taniguchi Y: The solubility of volatile anaesthetics in water at 25.0 degrees C using 19F NMR spectroscopy. J Pharm Biomed Anal 1992; 10:1-7
41. Warner DO, Vettermann J, Brichant JF, Rehder K: Direct and neurally mediated effects of halothane on pulmonary resistance in vivo. ANESTHESIOLOGY 1990; 72:1057-63
42. Brichant JF, Gunst SJ, Warner DO, Rehder K: Halothane, enflurane, and isoflurane depress the peripheral vagal motor pathway in isolated canine tracheal smooth muscle. ANESTHESIOLOGY 1991; 74:325-32
43. Mercier FJ, Naline E, Bardou M, Georges O, Denjean A, Benhamou D, Advenier C: Relaxation of proximal and distal isolated human bronchi by halothane, isoflurane and desflurane. Eur Respir J 2002; 20:286-92
44. Emala CW, Aryana A, Levine MA, Yasuda RP, Satkus SA, Wolfe BB, Hirshman CA: Expression of muscarinic receptor subtypes and M2-muscarinic inhibition of adenylyl cyclase in lung. Am J Physiol 1995; 268:L101-7
45. Stengel PW, Gomeza J, Wess J, Cohen ML: M(2) and M(4) receptor knockout mice: Muscarinic receptor function in cardiac and smooth muscle in vitro. J Pharmacol Exp Ther 2000; 292:877-85
46. Stengel PW, Yamada M, Wess J, Cohen ML: M(3)-receptor knockout mice: Muscarinic receptor function in atria, stomach fundus, urinary bladder, and trachea. Am J Physiol Regul Integr Comp Physiol 2002; 282:R1443-9
47. Roberts DJ, Waelbroeck M: G protein activation by G protein coupled receptors: Ternary complex formation or catalyzed reaction? Biochem Pharmacol 2004; 68:799-806
48. Lutz S, Freichel-Blomquist A, Yang Y, Rumenapp U, Jakobs KH, Schmidt M, Wieland T: The guanine nucleotide exchange factor p63RhoGEF, a specific link between Gq/11-coupled receptor signaling and RhoA. J Biol Chem 2005; 280:11134-9
49. Akam EC, Challiss RA, Nahorski SR: G(q/11) and G(i/o) activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: Dependence on agonist as well as receptor-subtype. Br J Pharmacol 2001; 132:950-8
50. 2+ sensitization of bronchial smooth muscle contraction in antigen-induced airway hyperresponsive rats. Br J Pharmacol 1999; 127:597-600
51. Seeman P, Kapur S: Anesthetics inhibit high-affinity states of dopamine D2 and other G-linked receptors. Synapse 2003; 50:35-40
52. Nietgen GW, Honemann CW, Chan CK, Kamatchi GL, Durieux ME: Volatile anaesthetics have differential effects on recombinant m1 and m3 muscarinic acetylcholine receptor function. Br J Anaesth 1998; 81:569-77
53. Eger EI II, Fisher DM, Dilger JP, Sonner JM, Evers A, Franks NP, Harris RA, Kendig JJ, Lieb WR, Yamakura T: Relevant concentrations of inhaled anesthetics for in vitro studies of anesthetic mechanisms. ANESTHESIOLOGY 2001; 94:915-21
54. Revich LR, Grinspon SG, Paredes C, Moreno E, Gene R, Jorge MA: Respiratory effects of halothane in a patient with refractory status asthmaticus. Pulm Pharmacol Ther 2001; 14:455-60